Rheumatoid arthritis breakthrough leads to hope for new treatments

Jesmond Dalli, Professor in Molecular Pharmacology at QMUL, said: “The study is important because it identifies for the first time the loss of RvT4 production as a potential new cause of blood vessel inflammation in the context of arthritis, offering a mechanistic explanation on the cause of this important disease in rheumatoid arthritis patients.”


This website uses cookies. By continuing to use this site, you accept our use of cookies.